A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the U.K.

British journal of cancer

Volumn 108, Issue 11, 2013, Pages 2250-2258

  Holt, S ^a   Bertelli, G ^b   Humphreys, I ^b   Valentine, W ^b   Durrani, S ^b   Pudney, D ^b   Rolles, M ^b   Moe, M ^b   Khawaja, S ^b   Sharaiha, Y ^b   Brinkworth, E ^b   Whelan, S ^b   Jones, S ^b   Bennett, H ^b   Phillips, C J ^b  

^a PRINCE PHILIP HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; COST BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT SYSTEM; ECONOMICS; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LYMPH NODE METASTASIS; METABOLISM; METHODOLOGY; MIDDLE AGED; PROBABILITY; STATISTICAL MODEL; UNITED KINGDOM;

ADULT; AGED; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT TECHNIQUES; FEMALE; GENE EXPRESSION PROFILING; GREAT BRITAIN; HUMANS; LYMPHATIC METASTASIS; MARKOV CHAINS; MIDDLE AGED; MODELS, ECONOMIC; RECEPTORS, ESTROGEN;

EID: 84884194413     PISSN: None     EISSN: 15321827     Source Type: None    
DOI: 10.1038/bjc.2013.207     Document Type: Article

References (0)